Dear Friend of DKT,
Last month, men around the world showed up to play their part in family planning. Alongside World Vasectomy Day and FP2030, DKT helped power a World Cup-inspired global campaign on July 17 that resulted in nearly 1,200 vasectomies across dozens of countries, proving that family planning is everyone’s responsibility.
In Rwanda, DKT East Africa logged its first-ever product sales, with condoms, IUDs, and other supplies reaching retailers and clinics. In Nigeria, an independent study with researchers from Tulane University confirmed what we’ve long believed: DKT’s supply chain investments there are working, generating tens of thousands of additional Couple-Years of Protection (CYPs) at decreasing cost as the program scales. And, also in Nigeria, DKT and DKT WomanCare launched a new long-acting hormonal IUD option, Avibela, in partnership with the government.
Thank you for your interest in our work. We are always happy to answer questions.
Cheers,
Christopher Purdy
Rwanda! First-ever product sales
DKT East Africa expanded its footprint this year with the launch of several family planning products in Rwanda; and July marked a milestone: the country’s first recorded sales! Condoms led the way, alongside IUDs, MVA supplies, and lubricants, all reaching Rwandan retailers and clinics for the very first time.
It’s an early step, but it reflects DKT’s continued commitment to bringing affordable and accessible reproductive health products to new markets across the region.
Independent look: Tulane study confirms DKT Nigeria’s Cost-Effectiveness
How do you know a public health investment is really working? The answer isn’t just reach but also measurable impact.
That’s why we’re excited to share a newly released independent Cost-Effectiveness Analysis conducted by researchers at Tulane University, led by Celia Scott Weatherhead from the School of Public Health and Tropical Medicine, assessing the impact and value for money of DKT Nigeria‘s Honey&Banana digital platform and Supply Chain Strengthening and Implementation project.
Using a rigorous quasi-experimental design, the study found the program generated more than 49,000 additional Couple-Years of Protection in its first six months alone, driven largely by increased uptake of implants and injectables. Just as encouraging: the cost of each additional Couple-Year of Protection is projected to fall from $14.45 to $3.33 as the program matures, proving that early investment in supply chains and digital tools compounds into greater impact and value over time.
Beyond the numbers, the findings reinforce how digital innovation, stronger health systems, and sustained investment can work together to expand access to family planning information, counseling, and quality services.
We’re grateful to Professor Paul Hutchinson, Professor Dominique Meekers, the Gates Foundation, and a special thank you to the DKT Nigeria team for this important, independent look at our work.
World Vasectomy Cup 2026: A record-setting day for men’s family planning participation
From June 17 to July 17, DKT joined World Vasectomy Day and FP2030 for the World Vasectomy Cup 2026 – a global campaign built around the World Cup’s spirit of teamwork and shared purpose, inviting men everywhere to see family planning as something they actively play a part in.
The campaign kicked off with a launch webinar, “The Role of Men in Sexual & Reproductive Health,” co-hosted by Hyam Bolande, Regional Director of DKT South America, alongside Dr. Samukeliso Dube of FP2030 and Dr. Esgar Guarin of World Vasectomy Day. It closed a month later with a conversation between Dr. Dominick Shattuck and DKT President Christopher Purdy on how marketing contraception to men has evolved, and what messages resonate most.
The result? 1,193 vasectomies were performed and 204 organizations across more than 40 countries took part. The campaign also launched a brand-new vasectomy clinic in Mexico and reached nearly 18,600 people through social media. It’s a striking reminder that when men are given the tools and the invitation to participate, they show up and family planning becomes stronger for it.
A new option for women in Nigeria – Avibela IUS; and new government partners for WomanCare
DKT Nigeria introduced Avibela, a hormonal IUS, giving Nigerian women a new long-acting contraceptive choice. More than 50 facilities have already stocked the product since launch, reflecting strong early interest from providers eager to expand the options available to their patients.
That momentum extended beyond Nigeria: DKT WomanCare sold Avibela and Levoplant to the government of Zambia through a tender, and, for the first time, sold implants to UNFPA Cabo Verde – opening a new country for the brand.
Together, these wins mark real progress in getting long-acting methods into the hands of governments and partners who can reach women at scale.
